Enliven Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.4M | 363k | 20.47 |
| 2025-06-30 | $6.1M | 306k | 20.06 |
| 2025-03-31 | $5.1M | 260k | 19.68 |
| 2024-12-31 | $5.9M | 262k | 22.50 |
| 2024-09-30 | $6.5M | 255k | 25.54 |
| 2024-06-30 | $5.4M | 231k | 23.37 |
| 2024-03-31 | $2.8M | 159k | 17.59 |
| 2023-12-31 | $2.2M | 158k | 13.84 |
| 2023-09-30 | $2.1M | 157k | 13.66 |
| 2023-06-30 | $1.3M | 63k | 20.41 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management